Suppr超能文献

目前用于预防和治疗男性和女性类固醇诱导性骨质疏松症的指征。

Current indications for prevention and therapy of steroid-iduced osteoporosis in men and women.

机构信息

Department of Endocrine Disoders and Bone Metabolism, 1st Chair of Endocrinology, Medical University, Łódz, Poland.

出版信息

Endokrynol Pol. 2011 Jan-Feb;62(1):38-44.

Abstract

Steroid-induced osteoporosis is a textbook example of the secondary type of this medical condition. Glucocorticosteroids suppress bone formation by their direct and indirect effect on osteoblasts, osteoclasts and osteocytes, increasing their resorption and, eventually, leading to negative bone balance. A clinical problem arises regarding the fact that approximately 50% of patients on chronic steroid therapy undergo asymptomatic bone fractures. The treatment mode includes minimising the dose of administered steroids, encouraging an improved lifestyle and supplementation with adequate calcium and vitamin D3 doses. Bisphosphonates are a group of medical agents used both to prevent and treat steroid-induced osteoporosis, although new therapies have also become available in recent years.

摘要

激素诱导性骨质疏松症是这种医学病症的继发性类型的典型例子。糖皮质激素通过其对成骨细胞、破骨细胞和骨细胞的直接和间接作用抑制骨形成,增加其吸收,最终导致负性骨平衡。大约 50%接受慢性类固醇治疗的患者出现无症状性骨折,这一临床问题出现了。治疗模式包括减少给予的类固醇剂量、鼓励改善生活方式以及补充足够的钙和维生素 D3 剂量。双膦酸盐是一组用于预防和治疗激素诱导性骨质疏松症的药物,尽管近年来也出现了新的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验